nach oben

Erschienen in:

01.06.2019 | Case report

Dupilumab

Ocular symptoms: case report

Erschienen in: Reactions Weekly | Ausgabe 1/2019

Einloggen, um Zugang zu erhalten

Excerpt

In a case series of 8 patients, one patient [age and sex not stated] was described, who developed ocular symptoms during compassionate treatment with dupilumab for atopic dermatitis [route and dosage not stated]. Eventually, the patient developed ocular symptoms, and within 2 months therapy with dupilumab was discontinued [duration of treatment to reaction onset and outcome not stated]. …

Ross G. The Royal Melbourne Hospital Atopic Dermatitis Clinic: First experience with dupilumab. Australasian Journal of Dermatology 60 (Suppl. 1): 6, May 2019 [abstract] - Australia

Titel: Dupilumab
Ocular symptoms: case report
Publikationsdatum: 01.06.2019
Verlag: Springer International Publishing
Erschienen in: Reactions Weekly / Ausgabe 1/2019
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI: https://doi.org/10.1007/s40278-019-63707-6

Springer Medizin

Dupilumab

Ocular symptoms: case report

Excerpt

Weitere Artikel der Ausgabe 1/2019

Tamoxifen

Somatrogon

Ciclosporin

Ibuprofen

Enoxaparin sodium

Antiepileptic drugs

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Tamoxifen

Somatrogon

Ciclosporin

Ibuprofen

Enoxaparin sodium

Antiepileptic drugs